Our results showed that despite the massive loss of striatal DAT, in the late phases of PD, we could still detect neuropathological alterations such as big PLA-positive clumps containing this protein in association with α-synuclein in specific areas showing a marked accumulation of α-synuclein pathology. Here, SLC6A3 is linked to Parkinson disease.